by Gary Pepper M.D. | Sep 5, 2016 | diabetes, general health & nutrition, Medical Economics, thyroid cancer
By Gary Pepper, M.D. A survey by metabolism.com reveals that a vast majority of the public believe doctors in the US are overly influenced in their decisions by the pharmaceutical industry. 500 visitors to the website participated in the survey. 419 (84%) answered... by Gary Pepper M.D. | Nov 30, 2014 | diabetes, health, health insurance, Medical Economics
By Gary Pepper, M.D. Have you noticed that medication costs are skyrocketing? Even if you don’t take medication these higher costs are passed along to you in your health insurance premiums. The recently enacted Sunshine Act will combat these economic forces but in... by Gary Pepper M.D. | Oct 6, 2014 | diabetes, Family Nutrition Diabetes, general health & nutrition, health insurance, Medical Economics
by Gary Pepper, M.D. “New is not always better.” This caution seems reasonable when considering the value of the recently approved medications for treatment of Type 2 (adult type) diabetes. Â These drugs include three new classes of medication referred to... by Gary Pepper M.D. | Jun 29, 2014 | general health & nutrition, health, Medical Economics, Uncategorized
by Dr. S. Brown As a physician in private practice familiar with highly skilled pharmaceutical representatives pitching the latest (and most expensive) medications, I am fairly good at separating truth from salesmanship. These clear cut interactions with the drug...
